Poietis

Executive Summary

Poietis is a French biotech company developing a next-generation laser-assisted bioprinting platform (NGB™) for creating complex 3D tissue models. Founded in 2014, the company targets applications in regenerative medicine and oncology, enabling high-precision fabrication of living tissues for research and potential therapeutic use. Poietis' technology addresses the growing need for physiologically relevant in vitro models, which can reduce animal testing and accelerate drug development. The platform's ability to print living cells with micrometer resolution positions it as a key player in the bioprinting space, with potential to revolutionize personalized medicine and tissue transplantation.

Upcoming Catalysts (preview)

• Q4 2026Strategic Partnership with a Major Pharmaceutical Company for Drug Screening Applications60% success
• Q2 2027Series B or C Funding Round to Scale Operations and Enter Clinical Trials50% success
• Q3 2026First Preclinical Data Publication Demonstrating In Vivo Efficacy of Bioprinted Tissue70% success